|
Procedural
delay bugs pharma R&D fund, DST floats EFC note
Jayashree
Padmini - New Delhi
It
may take some more time before the R&D fund mooted by the Dr
R A Mashelkar Committee is realized in absolute terms to be channelized
to research activities in the pharmaceutical segment. Recommended
long back and changed hands from the Department of Chemicals and
Petrochemicals to the Department of Science and Technology, the
fund is yet to reflect in the budget of DST. The department has
recently floated EFC note for the R&D fund and is awaiting response
from various departments towards finalizing the management portfolio
of the fund. Sources in DST told Express Pharma Pulse that the immediate
priority and the crux of the EFC note is to get transferred to the
department the Rs 150 crore corpus that the Finance Minister has
been harping on over the last two years.
Further,
the modalities of managing the fund has to be finalized. DST is
proposing to create a Drug Development Board to overlook the utilization
of the fund and is looking for incorporating provisions to make
the fund more industry friendly. The objective is to make it available
to industry independently as long-term loan whereas so far industry
had to approach in collaboration with institutions for availing
financial aid for research. The budget allocation for the department
this year has been jumped substantially from Rs 3.5 crore last year
to Rs 10 crore.
DST
this year is looking at focussing on three areas, say, veterinary
drug development, setting up CROs and anti-viral segment. In a bid
to bring in standardization in the veterinary drug segment and to
usher in original research the department is actively working at
multi-institutional - industry collaborative projects in the country.
Apart from ICAR and government funded Agricultural Universities,
the department will rope in CSIR too in the project.
Clinical
Research Organization is recognized as an arena of considerable
significance by the department where it is in talks with the National
Institute of Pharmaceutical Education & Research, informed the
source. Another major initiative identified for this year is developing
a national facility for screening antiviral drugs, to support and
direct research efforts towards developing NCEs to target viral
diseases in the country.
Ceiling
prices of Trimethoprim + Sulphadiazine tab revised
New
Delhi, 31 January, 2002
SO
146 (E) - In exercise of the powers, conferred by sub-paragraph
(1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices
Control) Order, 1995 read with SO No 637 (E) dated 4 September,
1997 issued by the Government of India in the Ministry of Chemicals
and Fertilisers and in supersession of the Order of the Government
of India in the Ministry of Chemicals and Fertilisers the National
Pharmaceutical Pricing Authority, hereby makes further amendments
in the Order of Government of India in the Ministry of Chemicals
and Fertilizers (National Pharmaceutical Pricing Authority) No SO
718 (E) dated 1 August, 2000, namely:
In
the said order, in the table below after serial number 1 and the
entries relating thereto, the following serial number and entries
relating thereto shall be added namely:
|
TABLE
|
|
Sl No
|
Name
of the Formulation
|
Strength
|
Pack
Size
|
Ceiling
Price (Rs)
|
|
|
|
Each
tab contains
|
|
|
|
7
|
Trimethoprim
+ Sulphadiazine Tab
|
Trimethorprim-180
mg, Sulphadiazine-820 mg
|
6’s
Al-St
|
8.16
|
|
8
|
Trimethoprim
+ Sulphadiazine Tab
|
Trimethoprim
-180 mg, Sulphadiazine -820 mg
|
6’s
Al-Bl
|
7.84
|
|
Note:
(a) The prices fixed are the maximum ceiling prices (exclusive of
excise duty and local taxes if any) for the specified pack and packs
of similar strength and companies cannot claim exemption on any
ground therefrom, unless specifically permitted by the Government/
NPPA through an order.
(b)
Pro-rata pricing for packs of same composition but of different
sizes will be applicable vide SO No 83 (E) dated 27/1/1998
(c)
For different packing material used or any special feature claimed
companies are required to approach NPPA for approval/ fixation of
specific prices.
(PN/58/2002/F/F
NO 8(36)2002)/DP/NPPA-Div-II)
Foot
Note: The Principal order was published in Part II, Section 3, Sub-section
(ii) of the Gazette of India vide No SO 614 (E) dated 1 August,
2000.
|
